Call for Paper - January 2024 Edition
IJCA solicits original research papers for the January 2024 Edition. Last date of manuscript submission is December 20, 2023. Read More

In Silico Protein-Ligand Docking Studies on Thiazolidinediones as Potential Anticancer Agents

Print
PDF
 
Download Full Text
International Journal of Computer Applications
© 2014 by IJCA Journal
Volume 95 - Number 6
Year of Publication: 2014
Authors:
Metta Madhuri
Cheepurupalli Prasad
Vasudeva Rao Avupati
10.5120/16597-6403

Metta Madhuri, Cheepurupalli Prasad and Vasudeva Rao Avupati. Article: In Silico Protein-Ligand Docking Studies on Thiazolidinediones as Potential Anticancer Agents. International Journal of Computer Applications 95(6):13-16, June 2014. Full text available. BibTeX

@article{key:article,
	author = {Metta Madhuri and Cheepurupalli Prasad and Vasudeva Rao Avupati},
	title = {Article: In Silico Protein-Ligand Docking Studies on Thiazolidinediones as Potential Anticancer Agents},
	journal = {International Journal of Computer Applications},
	year = {2014},
	volume = {95},
	number = {6},
	pages = {13-16},
	month = {June},
	note = {Full text available}
}

Abstract

Molecular docking study was performed on a series of 24 Thiazolidinediones MM1-MM24 as potential epiderma1 growth factor receptor (EGFRR) inhibitors. The docking technique was applied to dock a set of representative compounds within the active site region of 1M17 using Molegro Virtual Docker v 5. 0. For these compounds, the binding free energy (kcal/mol) was determined. The docking simulation clearly predicted the binding mode that is nearly similar to the crystallographic binding mode with 1. 34Ao RMSD. Based on the validations and hydrogen bond interactions made by R substituents were considered for evaluation. The results avail to understand the type of interactions that occur between thiazolidinediones with 1M17 binding site region and explain the importance of R substitution on thiazolidinedione basic nucleus.

References

  • Drews, J. (2000) Drug discovery: A historical Perspective. Scinece 247, 1960-1964.
  • Ohlstein, EH. , Ruffolo Jr. , R. R. , and Ellroff, J. D. (2000) Drug discovery in the next millennium. Annu. Rev. Pharmacol. Toxicol. 40, 177-191.
  • Royer RJ. Mechanism of action of adverse drug reactions: An overview. 1997; Pharmcoepidemiology and drug safety 6 (Suppl. ):S43-S50.
  • DiMasi JA, Bryant, NR, Lasagna L. (1991). New drug development in the United States from 1963 to 1990. Clin Pharmacol Ther. 50, 471-486.
  • Chen Y. Z. , and Zhi D. G. , (2001). Ligand-Protein Inverse Docking and Its Potential Use in Computer Search of Putative Protein Targets of a Small Molecule. Proteins, 43, 217-226
  • Chen Y. Z. , and Ung C. Y. (2002). Computer Automated Prediction of Putative Therapeutic and Toxicity Protein Targets of Bioactive Compounds from Chinese Medicinal Plants, Am. J. Chin. Med. , 30, 139-154. (2002).
  • Chen Y. Z. , and Ung C. Y. (2001). Prediction of Potential Toxicity and Side Effect Protein Targets of a Small Molecule by a Ligand-Protein Inverse Docking Approach. J. Mol. Graph. Mod. , 20, 199-218.
  • Cornell, WD, Cieplak P, Bayly CI, Gould IR, Merz KM Jr, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA. A second generation force field for the simulation of proteins and nucleic acids. J. Am. Chem. Soc. 1995; 117:5179-5197.
  • Lorber DM, Shoichet BK. Flexible ligand docking using conformational ensembles. Protein Sci. 7:938-950. 1998.
  • Schmidt TJ, Meyer AS. Autoregulation of corticosteroid receptors. How, when, where, and why? Receptor. 1994 Winter;4:229-257.
  • Sandak B, Wolfson HJ, Nussinov R. Flexible docking allowing induced fit in proteins: insights from an open to closed conformational isomers. Proteins 1998;32:159-174.
  • Noreen Y, Serrano G, Perera P, Bohlin L. Flavan-3-ols isolated from some medicinal plants inhibiting COX-1 and COX-2 catalysed prostaglandin biosynthesis. Planta Med. 64:520-524. 1998.
  • Nomura, S. ; Setsuko, G. ; Kazuhiko, I. ; Toru, N. ; Tomomitsu, O. ; Hisao, M. ; Osamu, K. ; Shigehiko, M. ; Yutaka, T. ; Molecular and Cellular Endocrinology. (1996), 124, 63.
  • Jakeman, L. B. ; Armanini, M. ; Phillips, H. S. ; Ferrara, N. Endocrinology. (1993), 133, 848.
  • Gehlhaar, D. K. ; Verkhivker, G. ; Rejto, P. A. ; Fogel, D. B. ; Fogel, L. J. ; Freer, S. T. (1995) Docking Conformationally Flexible Small Molecules Into a Protein Binding Site Through Evolutionary Programming. Proceedings of the Fourth International Conference on Evolutionary Programming, No 123-124.
  • Vasudeva Rao Avupati, Rajendra Prasad Yejella, Annapurna Akula, Girija Sankar Guntuku, Bhagya Raju Doddi, Venkata Rao Vutla, Suvarna Ratna Anagani, Lakshmana Santhi Adimulam and Aruna Kumar Vyricharla. Bioorganic & Medicinal Chemistry Letters, 22, 6442–6450.
  • Berman H M, Westbrook J, Feng Z, Gilliland G, Bhat T N, Weissig H, Shindyalov I N, Bourne P E (2000) The Protein Data Bank. Nucleic Acids Research, 24, 235-242.
  • Wang, J, Kollman, PA, Kuntz, ID. Flexible ligand docking: A multistep strategy approach. Proteins. 1999; 36:1-19. Bowman, M. , Debray, S. K. , and Peterson, L. L. 1993. Reasoning about naming systems.
  • Ramachandran, G. N. , Sasisekharan, V. (1968) Conformation of polypeptides and proteins. Adv. Protein Chem. 23, 243-438.
  • Vasudeva Rao Avupati, Purna Nagasree Kurre, Santoshi Rupa Bagadi, Muralikrishna Kumar Muthyala and Rajendra Prasad Yejella (2010) Denovo Based Ligand generation and Docking studies of PPAR? Agonists. Correlations between Predicted Biological activity LD. Biopharmaceutical Descriptors. 10, 74-86.
  • Storn, R. , Price, K. Differential Evolution - A Simple and Efficient Adaptive Scheme for Global Optimization over Continuous Spaces. Tech-report, International Computer Science Institute, Berkley, 1995.